Search research articles
Contact Us
Filters
Showing results (141-150 of 201) with videos related to
Page
of 21
Sort By:
Clinical Trials (London, England)
|
September 29, 2023
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1
Andrea M Gross, Scott R Plotkin, Nelson B Watts, et al.
Molecular Therapy. Methods & Clinical Development
|
July 18, 2022
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development
|
May 15, 2024
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Neurology
|
November 4, 2022
Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI
K Ina Ly, Vanessa L Merker, Wenli Cai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 27, 2026
Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated Pain
Zhenzhen Yin, Limeng Wu, Yanling Zhang, et al.
Neurology
|
August 17, 2016
Current status and recommendations for biomarkers and biobanking in neurofibromatosis
C Oliver Hanemann, Jaishri O Blakeley, Fabio P Nunes, et al.
Neurology
|
July 7, 2021
Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2
Srivandana Akshintala, Nashwa Khalil, Kaleb Yohay, et al.
Cancer Research
|
January 5, 2011
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape
Emmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2019
Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma
Elizabeth R Gerstner, Kyrre E Emblem, Ken Chang, et al.
Scientific Reports
|
November 22, 2018
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
K Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 201) with videos related to
Sort By:
Page
of 21
Clinical Trials (London, England)
|
September 29, 2023
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1
Andrea M Gross, Scott R Plotkin, Nelson B Watts, et al.
Molecular Therapy. Methods & Clinical Development
|
July 18, 2022
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development
|
May 15, 2024
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Neurology
|
November 4, 2022
Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI
K Ina Ly, Vanessa L Merker, Wenli Cai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 27, 2026
Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated Pain
Zhenzhen Yin, Limeng Wu, Yanling Zhang, et al.
Neurology
|
August 17, 2016
Current status and recommendations for biomarkers and biobanking in neurofibromatosis
C Oliver Hanemann, Jaishri O Blakeley, Fabio P Nunes, et al.
Neurology
|
July 7, 2021
Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2
Srivandana Akshintala, Nashwa Khalil, Kaleb Yohay, et al.
Cancer Research
|
January 5, 2011
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape
Emmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2019
Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma
Elizabeth R Gerstner, Kyrre E Emblem, Ken Chang, et al.
Scientific Reports
|
November 22, 2018
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
K Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Page
of 21